Aptose reschedules special meeting for Hanmi acquisition pending SEC clearance

Aptose Biosciences Inc.

Special meeting moved from Jan 16, 2026 to later date in January 2026.
Rescheduling due to awaiting final SEC clearance of proxy statement.
Unanimous board recommendation to vote for the continuance and arrangement.
Record date remains Dec 12, 2025; no changes to matters to be voted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.